Deletion of Ripk3 Prevents Motor Neuron Death In Vitro but not In Vivo

This work was supported by National Institute of Neurological Disorders and Stroke Grants NS099862, NS072428, and NS107442 (to S.P.), NS101966 (to E.J.P.-T.), NS101575 (to F.L.), and NS073776 (to L.L. and N.A.S.); the United States Department of Defense Award W81XWH-13-1-0416 (to S.P.); the Project-ALS/Columbia University Preclinical Core (F.L., N.A.S, and S.P.); Innovation Awards from the Thompson Family Foundation Initiative (S.P. and F.L.); the National Science Foundation Grant DGE 1644869 (to K.A.P.); the National Institutes of Health and National Center for Advancing Translational Sciences Grant TL1 TR000082-07 (to K.A.P.); the Medical Scientist Training Program GM007367 (to E.J.P.-T.); and the ALS Therapy Alliance (L.L. and N.A.S.).